Adenovirus mediated knockdown of bone morphogenetic protein 2 inhibits human lung cancer growth and invasion in vitro and in vivo

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 4, 2012, Pages 967-976

  Ye, X Y ^a   Niu, X M ^a   Tang, N W ^a   Xu, Y H ^a   Li, Z M ^a   Yu, Y F ^a   Lu, Shun ^a   Chen, Zhi Wei ^a  

^a SHANGHAI CHEST HOSPITAL   (China)

Author keywords

AKT; Bone morphogenetic protein 2; Growth; Invasion; Lung cancer; PBK

Indexed keywords

ADENOVIRUS VECTOR; BONE MORPHOGENETIC PROTEIN 2; GELATINASE B; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE P85ALPHA; PROTEIN KINASE B; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR VOLUME; ADENOVIRIDAE; CANCER CELL CULTURE; CANCER GROWTH; GENE EXPRESSION; HUMAN CELL CULTURE; LUNG CANCER; TUMOR INVASION;

EID: 84872937337     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500414     Document Type: Article

References (30)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90,
2. William WN Jr, Glisson BS. Novel strategies for the treatment of small-cell lung carcinoma. Nat Rev Clin Oncol 2011; 8:611-9.
3. Feng, XH, Derynck R. Specificity and versatility in TGF-signaling through Smads. Annu Rev Cell Dev Biol 2005; 21:659-693. (Pubitemid 41740650)
4. Miyazono K., Kamiya Y, Morikawa M. Bone morphogenetic protein receptors and signal transduction. J Biochem 2010; 147:35-51.
5. Kim M, Choe S. BMPs and their clinical potentials. BMB Rep 2011; 44:619-34.
6. Molina CA, Sarabia-Estrada R, Gokaslan ZL, et al. Delayed onset of paralysis and slowed tumor growth following in situ placement of recombinant human bone morphogenetic protein 2 within spine tumors in a rat model of metastatic breast cancer. J Neurosurg Spine 2012; 16:365-72.
7. Markić D, Ćelić T, Gršković A, et al. mRNA expression of bone morphogenetic proteins and their receptors in human renal cell carcinoma. Urol Int 2011; 87:353-8.
8. de Carvalho CH, Nonaka CF, de Araújo CR, et al. Immunoexpression of bone morphogenetic protein-2 (BMP-2), BMP receptor type IA, and BMP receptor type II in metastatic and non-metastatic lower lip squamous cell carcinoma. J Oral Pathol Med 2011; 40:181-6.
9. Soares AF, Xavier RL, da Costa Miguel MC, et al. Bone morphogenetic protein-2/4 and bone morphogenetic protein receptor type IA expression in metastatic and nonmetastatic oral squamous cell carcinoma. Am J Otolaryngol 2010; 31:266-71.
10. Liu C, Tian G, Tu Y, et al. Expression pattern and clinical prognostic relevance of bone morphogenetic protein-2 in human gliomas. Jpn J Clin Oncol 2009; 39:625-31.
11. Kwon H, Kim HJ, Rice WL, et al. Development of an in vitro model to study the impact of BMP-2 on metastasis to bone. J Tissue Eng Regen Med 2010; 4:590-9.
12. Clement JH, Raida M, Sänger J, et al. Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells. Int J Oncol 2005; 27:401-7.
13. Sotobori T, Ueda T, Myoui A, et al. Bone morphogenetic protein-2 promotes the haptotactic migration of murine osteoblastic and osteosarcoma cells by enhancing incorporation of integrin beta1 into lipid rafts. Exp Cell Res 2006; 312:3927-38. (Pubitemid 44633892)
14. Johnsen IK, Kappler R, Auernhammer CJ, et al. Bone morphogenetic proteins 2 and 5 are down-regulated in adrenocortical carcinoma and modulate adrenal cell proliferation and steroidogenesis. Cancer Res 2009; 69:5784-92.
15. Wang L, Park P, Zhang H, et al. BMP-2 inhibits the tumorigenicity of cancer stem cells in human osteosarcoma OS99-1 cell line. Cancer Biol Ther 2011; 11:457-63.
16. Ma Y, Ma L, Guo Q, et al. Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients. J Exp Clin Cancer Res 2010; 29:85.
17. Langenfeld EM, Kong Y, Langenfeld J. Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5. Oncogene 2006; 25:685-92. (Pubitemid 43214695)
18. Hsu YL, Huang MS, Yang CJ, et al. Lung tumor-associated osteoblast-derived bone morphogenetic protein-2 increased epithelial-to- mesenchymal transition of cancer by Runx2/Snail signaling pathway. J Biol Chem 2011; 286:37335-46.
19. Bieniasz M, Oszajca K, Eusebio M, et al. The positive correlation between gene expression of the two angiogenic factors: VEGF and BMP-2 in lung cancer patients. Lung Cancer 2009; 66:319-26.
20. Choi YJ, Kim ST, Park KH, et al. The serum bone morphogenetic protein-2 level in non-small-cell lung cancer patients. Med Oncol 2012; 29:582-8.
21. Jin H, Pi J, Huang X, Huang F, et al. BMP2 promotes migration and invasion of breast cancer cells via cytoskeletal reorganization and adhesion decrease: an AFM investigation. Appl Microbiol Biotechnol 2012; 93:1715-23.
22. Fong YC, Li TM, Wu CM, et al. BMP-2 increases migration of human chondrosarcoma cells via PI3K/Akt pathway. J Cell Physiol 2008; 217:846-55.
23. Hou CH, Hsiao YC, Fong YC, et al. Bone morphogenetic protein-2 enhances the motility of chondrosarcoma cells via activation of matrix metalloproteinase-13. Bone 2009; 44:233-42.
24. Wu JB, Fu HQ, Huang LZ, et al. Effects of siRNA-targeting BMP-2 on the abilities of migration and invasion of human liver cancer SMMC7721 cells and its mechanism. Cancer Gene Ther 2011; 18:20-5.
25. Chen X, Liao J, Lu Y, et al. Activation of the PI3K/Akt pathway mediates bone morphogenetic protein 2-induced invasion of pancreatic cancer cells Panc1. Pathol Oncol Res 2011; 17:257-61.
26. Graham TR, Odero-Marah VA, Chung LW, et al. PI3K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-kappaB in metastatic prostate cancer cells. Prostate 2009; 69:168-80.
27. Kang MH, Kang HN, Kim JL, et al. Inhibition of PI3 kinase/Akt pathway is required for BMP2-induced EMT and invasion. Oncol Rep 2009; 22:525-34.
28. Laack E, Scheffler A, Burkholder I, et al. Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC). Lung Cancer 2005; 50:51-8. (Pubitemid 41297469)
29. Buckley S, Shi W, Driscoll B, et al. BMP4 signaling induces senescence and modulates the oncogenic phenotype of A549 lung adenocarcinoma cells. Am J Physiol Lung Cell Mol Physiol 2004; 286:L81-6. (Pubitemid 38055861)
30. Chetty C, Lakka SS, Bhoopathi P, et al. MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells. Int J Cancer 2010; 127:1081-95.